News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

ASPARD staff

Articles by ASPARD staff

BillionPhotos.com/AdobeStock

APSARD 2025 Highlights New Frontiers, New Findings at Annual Conference

January 29th 2025

Showcasing cutting edge research and exploring best practices in ADHD diagnosis and treatment.

Latest Updated Articles

APSARD 2025 Highlights New Frontiers, New Findings at Annual Conference
Published: January 29th 2025 | Updated:

Trending on Psychiatric Times

Research Recap From the European College of Neuropsychopharmacology Congress

Southern California Psychiatry: Review of New Agents in Schizophrenia and Dementia

AI in 2025: A Look Back With Allen Frances, MD

Latest Alzheimer Disease Data: Reports from CTAD 2025

Breakage